Drug Patent Expirations for the week of February 26, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| OPTISON | Ge Healthcare | albumin human | 5,558,094 | Feb 28, 2012 | |||||
| GEODON | Pfizer | ziprasidone hydrochloride | 4,831,031 | Mar 2, 2012 | |||||
| GEODON | Pfizer | ziprasidone mesylate | 4,831,031 | Mar 2, 2012 | |||||
| GEODON | Pfizer Inc | ziprasidone hydrochloride | 4,831,031 | Mar 2, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
Tentative Approvals
| Ingredient | Tentative Approvals | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ziprasidone hydrochloride | 3 | ||||||||
*Tentative approvals are indicators of potential future generic entry. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment